QNCX Past Earnings image Quince Therapeutics Past Earnings

QNCX Past Earnings

— Presenting past earnings and revenue for Quince Therapeutics (QNCX) from Q2 2012 to Q4 2025, based on our latest update on 4/24/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these QNCX past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.
Quick links: Past Earnings  |  Past Revenue  |  FAQ
QNCX Past Earnings
PeriodPast Earnings DateGAAP
Q4 20254/10/2026-7.600
Q3 202511/12/2025-2.500
Q2 20258/11/2025-3.400
Q1 20255/13/2025-3.400
Q4 20243/24/2025-2.800
Q3 202411/13/2024-1.300
Q2 20248/13/2024-1.900
Q1 20245/13/2024-2.600
Q4 20234/1/2024-2.100
Q3 202311/14/2023-1.500
Q2 20238/4/2023-1.400
Q1 20235/15/2023-3.400
Q4 20223/15/2023-1.300
Q3 202211/9/2022-2.200
Q2 20228/9/2022-5.100
Q1 20225/10/2022-7.200
Q4 20213/1/2022-7.800
Q3 202110/29/2021-7.300
Q2 20218/6/2021-7.400
Q1 20215/6/2021-7.800
Q4 20203/2/2021-6.900
Q3 202011/12/2020-7.300
Q2 20208/17/2020-6.000
Q1 20205/12/2020-6.100
Q4 20193/17/2020-4.600
Q3 201911/12/2019-3.700
Q2 20198/9/2019-5.700
Q3 201311/7/20134.600
Q1 20135/9/20132.400
Q4 20123/14/20132.200
Q3 201211/6/2012-1.700
Q2 20128/9/20121.100
QNCX Past Revenue
PeriodPast Earnings DateGAAP
Q4 20254/10/2026NA
Q3 202511/12/2025NA
Q2 20258/11/2025NA
Q1 20255/13/2025NA
Q4 20243/24/2025NA
Q3 202411/13/2024NA
Q2 20248/13/2024NA
Q1 20245/13/2024NA
Q4 20234/1/2024NA
Q3 202311/14/2023NA
Q2 20238/4/2023NA
Q1 20235/15/2023NA
Q4 20223/15/2023NA
Q3 202211/9/2022NA
Q2 20228/9/2022NA
Q1 20225/10/2022NA
Q4 20213/1/2022NA
Q3 202110/29/2021NA
Q2 20218/6/2021NA
Q1 20215/6/2021NA
Q4 20203/2/2021NA
Q3 202011/12/2020NA
Q2 20208/17/2020NA
Q1 20205/12/2020NA
Q4 20193/17/2020NA
Q3 201911/12/2019NA
Q2 20198/9/2019NA
Q3 201311/7/201353.70M
Q1 20135/9/201338.00M
Q4 20123/14/201334.90M
Q3 201211/6/20120.02B
Q2 20128/9/201221.50M
Quotes delayed 20 minutes

Email EnvelopeFree QNCX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quince Therapeutics (QNCX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

QSI Past Earnings
QTRX Past Earnings
QTTB Past Earnings
RAIN Past Earnings
RANI Past Earnings
RAPP Past Earnings
RAPT Past Earnings
RARE Past Earnings
RBOT Past Earnings
RCEL Past Earnings

QNCX Past Earnings Q&A

What was the best and worst QNCX past earnings results?
For Quince Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest QNCX past earnings result in our data set was 4.600/share posted in Q3 2013, while the lowest was in Q4 2021 when QNCX posted -7.800/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2013 when QNCX reported 53.70M in revenue, while the quarter with the lowest revenue in our data set was Q4 2025 at NA of revenue.

  Suggested answer: There are 32 QNCX past earnings results in our data set.

On this page we presented the QNCX past earnings date information for Quince Therapeutics. Reviewing that QNCX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2013, when QNCX posted gaap of 4.600/share. Meanwhile the lowest QNCX past earnings result was in Q4 2021, when QNCX posted gaap of -7.800/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2013 when QNCX reported 53.70M in revenue, while the smallest revenue quarter was Q4 2025 when QNCX reported NA in revenue.

Any self directed investor doing their due diligence on QNCX or any other given stock can benefit from researching all of the Quince Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Quince Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for QNCX. Thanks for visiting, and the next time you need to research QNCX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

QNCX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.